日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural Complexity

冠状动脉支架植入术后长期服用阿司匹林与氯吡格雷的出血风险和手术复杂性比较

Kang, Jeehoon; Chung, Jaewook; Park, Kyung Woo; Bae, Jang-Whan; Lee, Huijin; Hwang, Doyeon; Yang, Han-Mo; Han, Kyoo-Rok; Moon, Keon-Woong; Kim, Ung; Rhee, Moo-Yong; Kim, Doo-Il; Kim, Song-Yi; Lee, Sung-Yun; Lee, Seung Uk; Kim, Sang-Wook; Kim, Seok Yeon; Han, Jung-Kyu; Shin, Eun-Seok; Koo, Bon-Kwon; Kim, Hyo-Soo

A Multi-Center, Prospective, Observational Study to Evaluate the Therapeutic Effectiveness and Safety of an Olmesartan/Amlodipine Plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia

一项多中心、前瞻性、观察性研究,旨在评估奥美沙坦/氨氯地平联合瑞舒伐他汀治疗合并高血压和血脂异常患者的疗效和安全性。

Lee, Bong-Ki; Kim, Byeong-Keuk; Park, Jae Hyoung; Chung, Jong-Won; Park, Chang Gyu; Kim, Jin Won; Kim, Young Dae; Park, Woo-Jung; Kim, Sang-Hyun; Cha, Jae-Kwan; Kim, Cheol Ho; Rha, Seung-Woon; Hong, Young Joon; Shin, Mi-Seung; Cho, Seong Wook; Sung, Young-Hee; Lee, Kiheon; Yu, Jae-Myung; Ryu, Dong-Ryeol; Yu, Sungwook; Song, Tae-Jin; Ku, Bon D; Kim, Sin-Gon; Park, Hwan-Cheol; Cho, Deok-Kyu; Kim, Byung-Su; Han, Seong-Woo; Park, Sung-Ji; Park, Gyung-Min; Han, Kyoo-Rok

Correction: Comparison of 2‑year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry

更正:急性心肌梗死后病情稳定的2型糖尿病患者中,根据肥胖情况比较2年死亡率:来自DIAMOND前瞻性队列登记研究的结果

Won, Ki-Bum; Hur, Seung-Ho; Cho, Yun-Kyeong; Yoon, Hyuck-Jun; Nam, Chang-Wook; Kim, Kwon-Bae; Bae, Jang-Ho; Choi, Dong-Ju; Ahn, Young-Keun; Park, Jong-Seon; Kim, Hyo-Soo; Choi, Rak-Kyeong; Choi, Donghoon; Kim, Joon-Hong; Han, Kyoo-Rok; Park, Hun-Sik; Choi, So-Yeon; Yoon, Jung-Han; Kwon, Hyeon-Cheol; Rha, Seung-Woon; Hwang, Kyung-Kuk; Lim, Do-Sun; Jung, Kyung-Tae; Oh, Seok-Kyu; Lee, Jae-Hwan; Shin, Eun-Seok; Kim, Kee-Sik

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia

一项随机、多中心、平行、开放标签的4期研究,旨在比较瑞舒伐他汀/氨氯地平复方制剂与阿托伐他汀/氨氯地平复方制剂在高血压合并血脂异常患者中的疗效和安全性。

Jung, Hae Won; Kim, Chang-Yeon; Hong, Seung-Pyo; Bae, Han-Joon; Choi, Ji Yong; Ryu, Jae Kean; Lee, Jin-Bae; Lee, Kyoung-Hoon; Han, Kyoo-Rok; Yang, Dong-Heon; Park, Chang-Gyu; Yu, Gheol-Woong; Rhee, Moo-Yong; Park, Sung-Ji; Hyon, Min-Su; Shin, Joon-Han; Hong, Bum-Kee; Jin, Han-Young; Lee, Sung-Yun; Seol, Sang-Hoon; Lee, Sang-Rok; Kim, Song-Yi; Lee, Kwang-Je; Cho, Eun-Joo; Nam, Chang-Wook; Park, Tae-Ho; Kim, Ung; Kim, Kee-Sik

Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function

根据肾功能对急性冠脉综合征患者进行普拉格雷降阶治疗

Yun, Jun Pil; Kang, Jeehoon; Park, Kyung Woo; Park, Kyungil; Hwang, Doyeon; Han, Jung-Kyu; Yang, Han-Mo; Kang, Hyun-Jae; Koo, Bon-Kwon; Chae, In-Ho; Moon, Keon-Woong; Park, Hyun Woong; Won, Ki-Bum; Jeon, Dong Woon; Han, Kyoo-Rok; Choi, Si Wan; Ryu, Jae Kean; Jeong, Myung Ho; Kim, Hyo-Soo

Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI

在接受经皮冠状动脉介入治疗的STEMI患者中,基于普拉格雷的双联抗血小板治疗降阶方案

Ki, You-Jeong; Lee, Bong Ki; Park, Kyung Woo; Bae, Jang-Whan; Hwang, Doyeon; Kang, Jeehoon; Han, Jung-Kyu; Yang, Han-Mo; Kang, Hyun-Jae; Koo, Bon-Kwon; Kim, Dong-Bin; Chae, In-Ho; Moon, Keon-Woong; Park, Hyun Woong; Won, Ki-Bum; Jeon, Dong Woon; Han, Kyoo-Rok; Choi, Si Wan; Ryu, Jae Kean; Jeong, Myung Ho; Cha, Kwang Soo; Kim, Hyo-Soo

Erratum: Correction of Text in the Article "Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI"

勘误:更正文章“基于普拉格雷的STEMI患者经皮冠状动脉介入治疗后双联抗血小板治疗降阶梯方案”中的文本

Ki, You-Jeong; Lee, Bong Ki; Park, Kyung Woo; Bae, Jang-Whan; Hwang, Doyeon; Kang, Jeehoon; Han, Jung-Kyu; Yang, Han-Mo; Kang, Hyun-Jae; Koo, Bon-Kwon; Kim, Dong-Bin; Chae, In-Ho; Moon, Keon-Woong; Park, Hyun Woong; Won, Ki-Bum; Jeon, Dong Woon; Han, Kyoo-Rok; Choi, Si Wan; Ryu, Jae Kean; Jeong, Myung Ho; Cha, Kwang Soo; Kim, Hyo-Soo

The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 & 2016 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry

韩国经皮冠状动脉介入治疗现状:基于2014年和2016年韩国经皮冠状动脉介入治疗(K-PCI)注册研究队列

Shin, Dong Ho; Kang, Hyun Jae; Jang, Jae Sik; Moon, Keon Woong; Song, Young Bin; Park, Duk Woo; Bae, Jang Whan; Kim, Juhan; Hur, Seung Ho; Kim, Byung Ok; Jeon, Dong Woon; Choi, Donghoon; Han, Kyoo Rok

A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy

一项多中心、随机、双盲IV期临床试验,旨在比较氨氯地平乳清酸盐/缬沙坦5/160 mg固定剂量复方制剂与缬沙坦/氢氯噻嗪160/12.5 mg复方制剂在缬沙坦160 mg单药治疗控制不佳的原发性高血压患者中的疗效和安全性。

Ahn, Youngkeun; Kim, Yongcheol; Chang, Kiyuk; Kim, Weon; Rhee, Moo-Yong; Cha, Kwang Soo; Hyon, Min Su; Shim, Chi Young; Lee, Sung Yun; Kim, Doo Il; Kim, Sang Wook; Lim, Sang-Wook; Han, Kyoo-Rok; Jo, Sang-Ho; Lee, Nae-Hee; Kwan, Jun; Ahn, Taehoon

Transradial versus transfemoral intervention in non-ST-segment elevation acute coronary syndrome patients undergoing percutaneous coronary intervention: the Korean transradial intervention registry of 1 285 patients

经桡动脉与经股动脉介入治疗在非ST段抬高型急性冠脉综合征患者经皮冠状动脉介入治疗中的比较:韩国1285例经桡动脉介入治疗患者的注册研究

Lee, Min-Ho; Bang, Duk Won; Park, Byung Won; Cho, Byung-Ryul; Rha, Seung-Woon; Jeong, Myung Ho; Yoon, Junghan; Suh, Jon; Han, Kyoo-Rok; Hyon, Min Su